Current approved therapeutic strategies for IPF and LC treatment.

The oncogenic landscape of the idiopathic pulmonary fibrosis: a

Targeting Molecular and Cellular Mechanisms in Idiopathic

Up-regulated SPP1 increases the risk from IPF to lung cancer via

Network Pharmacology Prediction and Molecular Docking-Based

Beatrice ARAMINI, MD PhD

Potential Therapeutic Targets of Resveratrol in the Prevention and

Dario Andrisani's research works Università degli Studi di Modena e Reggio Emilia, Modena (UNIMO) and other places

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis : new concepts in pathogenesis and

A Review of the Treatment and Management of Idiopathic Pulmonary

Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic

Stefania CERRI, Assistant Professor, MD, PhD, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

The oncogenic landscape of the idiopathic pulmonary fibrosis: a

PDF) Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development